As compared to control or ICBs, guadecitabine alone and in combination with ICBs upregulated T cell responses by increasing granzyme production on tumor infiltrating CD8+ T cells, favoring the maturation of CD8+T cells in effector memory (CD44+CD62L-) cells secreting granzyme (Fig. 3B). Here, SELL is linked to neoplasm.